Rafael Holdings subsidiary, Cyclo Therapeutics is planning to submit a NDA to US regulators for Trappsol Cyclo in NPC despite the primary endpoint miss. Credit: Kateryna Kon / Shutterstock.com. Rafael ...
Oral semaglutide maintains weight-loss progress after injectable GLP-1 therapy, strengthening its case as an oral alternative.
Invivyd’s Covid-targeting mAb was proven more safe and tolerable than Pfizer and BioNTech’s Comirnaty as per the trial’s endpoints. Credit: Corona Borealis Studio / Shutterstock.com. Invivyd’s ...
ALS is a fatal neurodegenerative condition with no cure and limited treatment options for symptom management. Credit: Andrzej Rostek/Shutterstock.com. VectorY Therapeutics has expanded the study size ...
Vasomune Therapeutics will focus on data quality, review, cleaning, site closeout, and database lock preparations. Credit: PanuShot / Shutterstock.com. Vasomune Therapeutics has completed enrolment in ...
Kodiak will file for Zenkuda’s approval in wAMD following these positive results. Credit: recep kart / Shutterstock.com. Kodiak Sciences’ stock has soared by upwards of 90% after securing a duo of ...
The Clinical Trials Arena editorial team brings you the highlights from the IMS 2026 Congress in Glasgow, Scotland. Credit: David A Litman / Shutterstock.com. In recent years, the multiple myeloma ...
The bispecific antibody is intended for treating advanced gastric cancer. Credit: SewCreamStudio/Shutterstock.com. Akeso has commenced a global Phase III clinical ...
With the latest expansion, the trial will consist of two substudies, one focusing on squamous NSCLC and the other on non-squamous NSCLC. Credit: bangoland/Shutterstock.com. Innovent Biologics has ...
Acadia is continuing its Phase III studies on remlifanserin in ADP with some protocol amendments. Credit: Chinnapong / Shutterstock.com. Acadia Pharmaceuticals has deemed the results of its Phase II ...
SPS is a rare, progressive autoimmune neurological disorder that causes severe muscle stiffness, rigidity, and painful spasms. Credit: Jack_the_sparow / Shutterstock.com Kyverna Therapeutics’ Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results